ANTIFUNGAL THERAPY IN ‘BONE MARROW FAILURE’

This publication has 58 references indexed in Scilit:

• Fungal infections and the cancer patient
  European Journal Of Cancer, 1997
• Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
  Bone Marrow Transplantation, 1997
• Prophylaxis and therapy of infections in neutropenic patients
  Current Opinion in Infectious Diseases, 1996
• Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial
  European Journal Of Cancer, 1996
• Lipid Formulations of Amphotericin B
  Drug Safety, 1995
• Orointestinal yeast colonization of paediatric bone marrow transplant recipients: surveillance by quantitative culture and serology
  Mycoses, 1995
• Management of infections in neutropenic patients: new opportunities and emerging challenges
  Current Opinion in Infectious Diseases, 1994
• Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• Empiric amphotericin B therapy: the need for a reappraisal
  Blood Reviews, 1993
• Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment
  European Journal Of Cancer, 1992